Literature DB >> 11819291

Therapeutic effect of Zijin capsule in liver fibrosis in rats.

Da-Yong Cai, Gang Zhao, Jia-Chun Chen, Gan-Mei Ye, Fei-Hong Bing, Bu-Wu Fan.   

Abstract

AIM:To confirm the therapeutic effect of Zijin capsule on liver fibrosis in rat model.
METHODS: Model group: Bovine serum albumin (BSA) Freund's incomplete adjuvant 0.5ml was injected subdermally at d(1) d(15) d(22) d(29) and d(36) for primary sensitization. Seven days after the fifth injection, BSA antibody in the serum was detected by double agar diffusion method. Normal saline of 0.4ml was injected through cauda vein to BSA antibody-positive rat twice a week for fifteen times. Traditional Chinese medicine (TCM) decoction group and Zijin capsule group: In the attack injection period, Chinese medicinal decoction or Zijin capsule was given ig, the others were the same as in the model group. NS was used in the control group. The collagen content of rat liver was determined by Bergman's method and expressed as x-±s.The liver pathological changes were divided into four grades and expressed as the avarage of the total rank sum.
RESULTS: The collagen content (mg/g) of the liver in the control group (7.2± 1.9) was significantly lower than that in the other groups; it was higher in the model group (31.7± 16.6) than that in the two therapeutic groups; and lower in Zijin capsule group (9.7 ± 2.8) than that in the TCM decoction group (11.5± 5.3). The pathological changes were more aggravated in the model group (37.4) than those in the two therapeutic groups; and more severe in the TCM decoction group (30.2) than in the Zijin capsule group (22.9).
CONCLUSION: The therapeutic effect of Zijin capsule on the model was confirmed.

Entities:  

Year:  1998        PMID: 11819291      PMCID: PMC4723472          DOI: 10.3748/wjg.v4.i3.260

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  5 in total

1.  Effect of compound rhodiola sachalinensis A Bor on CCl4-induced liver fibrosis in rats and its probable molecular mechanisms.

Authors:  Xiao-Ling Wu; Wei-Zheng Zeng; Pi-Long Wang; Chun-Tao Lei; Ming-De Jiang; Xiao-Bin Chen; Yong Zhang; Hui Xu; Zhao Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

2.  Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl(4).

Authors:  Hong-Shan Wei; Ding-Guo Li; Han-Ming Lu; Yu-Tao Zhan; Zhi-Rong Wang; Xin Huang; Jing Zhang; Ji-Lin Cheng; Qin-Fang Xu
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

3.  The regulatory role of AT 1 receptor on activated HSCs in hepatic fibrogenesis:effects of RAS inhibitors on hepatic fibrosis induced by CCl(4).

Authors:  Hong-Shan Wei; Han-Ming Lu; Ding-Guo Li; Yu-Tao Zhan; Zhi-Rong Wang; Xin Huang; Ji-Lin Cheng; Qin-Fang Xu
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

4.  Experimental study of effect of Ganyanping on fibrosis in rat livers.

Authors:  Wang-Xian Tang; Zi-Li Dan; Hong-Mei Yan; Cui-Huan Wu; Guo Zhang; Mei Liu; Qin Li; Shao-Bai Li
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

5.  11β‑hydroxysteroid dehydrogenase‑1 is associated with the activation of hepatic stellate cells in the development of hepatic fibrosis.

Authors:  Wei Xiao; Meng-Hou Lu; Peng-Fei Rong; Hao-Ye Zhang; Jian Gong; Ying-Qiong Peng; Huan-Yu Gong; Zhen-Guo Liu
Journal:  Mol Med Rep       Date:  2020-08-07       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.